MedTrace Logo

Effects of Action Observation Therapy in Geriatric Individuals

NCT07418970 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2026-02-18

No results posted yet for this study

Summary

This randomized controlled trial aimed to investigate the effects of Action Observation Therapy (AOT) on cognitive function, balance, fatigue, and functional capacity in geriatric individuals. Participants aged 65 years and older were randomly assigned to one of three groups: a control group, an exercise group, or an action observation therapy group. The intervention period lasted 8 weeks. The exercise group received a conventional exercise program, while the action observation therapy group watched exercise videos before performing the same exercises. The control group did not participate in any structured exercise program during the study period. Outcome measures included cognitive function, balance performance, fatigue levels, and functional capacity. The study evaluated whether adding action observation therapy to conventional exercise provides additional benefits in older adults.

Conditions

  • Cognitive Function
  • Balance Impairment
  • Fatigue
  • Aging

Interventions

OTHER

Action

exercise

OTHER

Action Observation Therapy

Based on exercise recommendations for older adults from the American College of Sports Medicine (ACSM), the researcher developed a conventional exercise training programme suitable for participants aged 65 and over, incorporating balance, strength and flexibility exercises. In parallel, an action observation therapy exercise video recording was prepared for the experimental group participants. The exercises were easy to learn, not complex in terms of memory and performance, performed standing up without sitting down, and progressed from easy to difficult. The exercise programme was carried out for a total of 16 sessions over four weeks, with 8 repetitions per set for the first four weeks and 12 repetitions per set for the next four weeks, for 30-45 minutes, twice a week. Participants in the control group were informed that they would be enrolled in their preferred exercise programme afterwards, and no exercise programme was implemented throughout the study. The same exercise program

Sponsors & Collaborators

  • Hasan Kalyoncu University

    lead OTHER

Principal Investigators

  • Ilker Demir, PhD · Hasan Kalyoncu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-10-01
Completion
2025-11-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07418970 on ClinicalTrials.gov